
Kissei Pharmaceutical Co Ltd
TSE:4547

Intrinsic Value
The intrinsic value of one
Kissei Pharmaceutical Co Ltd
stock under the Base Case scenario is
2 611.06
JPY.
Compared to the current market price of 3 710 JPY,
Kissei Pharmaceutical Co Ltd
is
Overvalued by 30%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Kissei Pharmaceutical Co Ltd
Fundamental Analysis


Revenue & Expenses Breakdown
Kissei Pharmaceutical Co Ltd
Balance Sheet Decomposition
Kissei Pharmaceutical Co Ltd
Current Assets | 106.8B |
Cash & Short-Term Investments | 44.5B |
Receivables | 32.9B |
Other Current Assets | 29.4B |
Non-Current Assets | 142.2B |
Long-Term Investments | 92.1B |
PP&E | 26B |
Intangibles | 1.9B |
Other Non-Current Assets | 22.3B |
Free Cash Flow Analysis
Kissei Pharmaceutical Co Ltd
JPY | |
Free Cash Flow | JPY |
Earnings Waterfall
Kissei Pharmaceutical Co Ltd
Revenue
|
83.4B
JPY
|
Cost of Revenue
|
-41.5B
JPY
|
Gross Profit
|
41.9B
JPY
|
Operating Expenses
|
-37.8B
JPY
|
Operating Income
|
4.1B
JPY
|
Other Expenses
|
7.6B
JPY
|
Net Income
|
11.7B
JPY
|
Profitability Score
Profitability Due Diligence
Kissei Pharmaceutical Co Ltd's profitability score is 47/100. The higher the profitability score, the more profitable the company is.

Score
Kissei Pharmaceutical Co Ltd's profitability score is 47/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Kissei Pharmaceutical Co Ltd's solvency score is 96/100. The higher the solvency score, the more solvent the company is.

Score
Kissei Pharmaceutical Co Ltd's solvency score is 96/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Kissei Pharmaceutical Co Ltd
According to Wall Street analysts, the average 1-year price target for
Kissei Pharmaceutical Co Ltd
is 3 965.25 JPY
with a low forecast of 3 484.5 JPY and a high forecast of 4 830 JPY.
Dividends
Current shareholder yield for Kissei Pharmaceutical Co Ltd is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
Kissei Pharmaceutical Co Ltd
stock under the Base Case scenario is
2 611.06
JPY.
Compared to the current market price of 3 710 JPY,
Kissei Pharmaceutical Co Ltd
is
Overvalued by 30%.